1. FDA approves Sarepta’s DMD drug that it had previously rejected — Biogen chalks up another failure — The House passes the Lower Drug Costs Now Act, but it’s unlikely to become law — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

9 open territories for Neurology

Discussion in 'Promius Pharma' started by anonymous, Nov 2, 2018 at 1:28 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    There are now 9 Field Sales Neurology positions listed on the Dr. Reddy's website. The open territories seem to be growing on a daily basis at this point.
     

  2. anonymous

    anonymous Guest

    Not ar surprise. All are looking.
     
  3. anonymous

    anonymous Guest

    Low pay, low commission. Bad management.
     
  4. anonymous

    anonymous Guest

    The industry standard is to ruin something otherwise perfectly fine.
     
  5. anonymous

    anonymous Guest

    Managed Care coverage for the neuro product is lousy, compared to competitors. There are generic options and new products are a lot better. This place is doomed.
     
  6. anonymous

    anonymous Guest

    It’s an expansion. 2 open territories and 7 new.